Back to Products
Tablet
MOKSOKOR-CV 625
Amoxycillin (500 mg), Clavulanic Acid (125 mg)
Empower your clinical outcomes with MOKSOKOR-CV 625, containing Amoxycillin (500 mg), Clavulanic Acid (125 mg), manufactured under strict WHO-GMP compliance by Ramitra Biotech in 10 x 1 x 10 Aluminium packing to ensure maximum purity and bioavailability.
📋 Specifications
| Product Name | MOKSOKOR-CV 625 |
|---|---|
| Composition | Amoxycillin (500 mg), Clavulanic Acid (125 mg) |
| Category | Tablet |
| Packaging | 10 x 1 x 10 Aluminium |
| Certifications | WHO-GMP Certified / ISO 9001:2015 Approved |
| Franchise Availability | Available for PCD Franchise |
Product Indications & Details
MOKSOKOR-CV 625 is a high-potency antibacterial tablet formulation designed to combat a wide range of bacterial infections effectively.
Combines Amoxycillin 500 mg with Clavulanic Acid 125 mg to provide powerful broad-spectrum coverage and overcome bacterial resistance.
Clavulanic Acid acts as a beta-lactamase inhibitor that prevents bacterial inactivation of Amoxycillin, ensuring maximum therapeutic efficacy.
Indicated for the treatment of respiratory tract infections, urinary tract infections, skin and soft tissue infections, and dental conditions.
Supplied in durable 10 x 1 x 10 aluminium blister packaging to shield the medication from moisture and maintain shelf-life stability.
Manufactured by Ramitra Biotech under stringent quality standards to ensure clinical reliability and optimal patient care.
Quantity
